Pharmaceutical preparations company · DE · FY ends Mar
ROIC dropped from -66.62% to -192.42%, capital efficiency is deteriorating. Negative free cash flow of -$4M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$0.00
Net Income (TTM)
-$5M
▼ -10.5% YoY
Op. Margin
—
ROIC
-192.42%
▼ -125.8pp YoY
Cash Flow & Balance Sheet
FCF (FY)
-$4M
▼ -9.4% YoY
Op. Cash Flow (FY)
-$4M
▼ -13.8% YoY
Net Debt
$943K
Cash & Equiv.
$2M
Continue Research